BlackRock Institutional Trust’s Acorda Therapeutics ACOR Stock Holding History

BlackRock Institutional Trust’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$23.5M	Sell	10,405 -466	-4%	-$1.11M	﹤0.01%	1850
2016 Q3	$27.2M	Buy	10,871 +68	+0.6%	+$203K	﹤0.01%	1665
2016 Q2	$33.1M	Buy	10,803 +660	+7%	+$2.15M	0.01%	1506
2016 Q1	$32.2M	Buy	10,143 +593	+6%	+$2.46M	0.01%	1505
2015 Q4	$49M	Buy	9,550 +24	+0.3%	+$105K	0.01%	1252
2015 Q3	$30.3M	Sell	9,526 -217	-2%	-$842K	0.01%	1549
2015 Q2	$39M	Sell	9,743 -318	-3%	-$1.23M	0.01%	1448
2015 Q1	$40.2M	Buy	10,061 +214	+2%	+$980K	0.01%	1462
2014 Q4	$48.3M	Sell	9,847 -97	-1%	-$416K	0.01%	1319
2014 Q3	$40.4M	Sell	9,944 -319	-3%	-$1.2M	0.01%	1397
2014 Q2	$41.5M	Buy	10,263 +244	+2%	+$995K	0.01%	1447
2014 Q1	$45.6M	Sell	10,019 -2,524	-20%	-$10.2M	0.01%	1341
2013 Q4	$43.9M	Buy	12,543 +3,055	+32%	+$11.9M	0.01%	1356
2013 Q3	$38.9M	Sell	9,488 -165	-2%	-$711K	0.01%	1366
2013 Q2	$38.2M	Buy	+9,653	New	+$39.7M	0.01%	1322

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock Institutional Trust's ACOR Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Acorda Therapeutics (ACOR) stake by 4.3% in Q4 2016, selling an estimated $1.11M and leaving 10,405 shares worth $23.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

BlackRock Institutional Trust first reported a position in ACOR in Q2 2013 and has held it in 15 quarters since. The position peaked at $49M in Q4 2015. 175 funds tracked by Wall St. Rank hold ACOR as of Q4 2016.

BlackRock Institutional Trust held 10,405 shares of Acorda Therapeutics worth $23.5M as of Q4 2016.
BlackRock Institutional Trust sold 466 Acorda Therapeutics shares in Q4 2016, an estimated $1.11M.
Acorda Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1850 holding.
BlackRock Institutional Trust first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Acorda Therapeutics position peaked at $49M in Q4 2015.
175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.